Yong Wang

LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models

S. Betty Yan, Victoria L. Peek, Rose T. Ajamie et al. · Investigational New Drugs · 2012 · 159 citations · Full text

LY2875358, a Neutralizing and Internalizing Anti-MET Bivalent Antibody, Inhibits HGF-Dependent and HGF-Independent MET Activation and Tumor Growth

Ling Liu, Wei Zeng, Mark A. Wortinger et al. · Clinical Cancer Research · 2014 · 105 citations

A high-resolution emission inventory of anthropogenic trace elements in Beijing-Tianjin-Hebei (BTH) region of China

Chuanyong Zhu, Hezhong Tian, Yan Hao et al. · Atmospheric Environment · 2018 · 87 citations

Environmental Chemistry, Chemical Emission, Environmental Monitoring +12

Praziquantel ameliorates CCl₄‐induced liver fibrosis in mice by inhibiting TGF‐β/Smad signalling via up‐regulating Smad7 in hepatic stellate cells

Jinfeng Liu, Delong Kong, Jingfan Qiu et al. · British Journal of Pharmacology · 2019 · 83 citations · Full text

Differences in iNOS and Arginase Expression and Activity in the Macrophages of Rats Are Responsible for the Resistance against T. gondii Infection

Zhi Li, Zhi‐Jun Zhao, Xing‐Quan Zhu et al. · PLoS ONE · 2012 · 76 citations · Full text

Microbial Pathogens, Immunology, Innate Immunity +17